Affordable Insulin Now Act of 2026

Key Points

• Starting in 2027, private health insurance plans must cover at least one of every type and dosage form of insulin (rapid-acting, long-acting, premixed, etc.) with out-of-pocket costs capped at $35 or 25% of the negotiated price, whichever is less, per 30-day supply.
• Insurance plans cannot charge a deductible for covered insulin products, meaning patients get the lower price from day one without having to meet a spending threshold first.
• The bill creates a new federal program for uninsured people. The government would reimburse pharmacies and health care providers to ensure uninsured patients also pay no more than $35 per month for insulin.
• The $35 copay payments still count toward a patient's deductible and annual out-of-pocket maximum, helping them reach their insurance limits faster and reducing total healthcare costs for the year.
• The rules apply broadly across private coverage types, including employer-sponsored group plans (through ERISA and the Internal Revenue Code) and individual marketplace plans, as well as catastrophic plans sold on the ACA exchange.
• The bill does not include a funding mechanism to pay for these changes. Instead, it includes a nonbinding statement that Congress should pass future legislation to offset the costs.

Votes

No votes have been recorded for this legislation yet.

Related Bills

No related bills have been identified yet.